Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer receives 'refuse to file' letter from FDA for compound tafamidis
Pfizer receives 'refuse to file' letter from FDA for compound tafamidis
Pfizer receives 'refuse to file' letter from FDA for compound tafamidis
Submitted by
admin
on April 4, 2011 - 9:06am
Source:
Yahoo/AP
News Tags:
FDA
tafamidis
Pfizer
transthyretin familial amyloid polyneuropathy
Headline:
Pfizer receives 'refuse to file' letter from FDA for compound tafamidis
Do Not Allow Advertisers to Use My Personal information
